![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
Advertisement
All
>
Persons > Northern Europe
Please find below persons from Denmark, Estonia, Finland, Iceland, Ireland, Latvia, Lithuania, Norway, Sweden and the UK as well as related to organisations from these countries.Total search results: 4175 | Ordered by Country (ascending)
1 2 3 ... 39 40 41 42 
  Person |
Position |
Organisation (Group) |
 Country |
|---|---|---|---|
| Thornton, Laura (Consilium Strategic Communications 201602) | Public Relations Manager / Investor Relations Manager | ICR (Group) | United Kingdom (GB) |
| Tierney, Dermot (Amply Diagnostics 202402 COO + Co-Founder) | Chief Operating Officer (COO) | Amply Discovery Ltd. | United Kingdom (GB) |
| Tilbury, Jon (Tessella 200904 Director) | n. a. | Tessella (Group) | United Kingdom (GB) |
| Tipper, Liezel (MRC Technology 201507 PR + Communications Manager) | Public Relations Manager / Investor Relations Manager | LifeArc (GB) | United Kingdom (GB) |
| Tisi, Laurence (Lumora 200301 CEO + founder) | Chief Executive Officer (CEO) | Erba Diagnostics Mannheim (Group) | United Kingdom (GB) |
| Tite, John (Bicycle Therapeutics 200910–201203c CEO) | Chief Executive Officer (CEO) | Bicycle Therapeutics (Group) | United Kingdom (GB) |
| Titman, Christopher M. (Shimadzu 201109 Life Science + Mass Spec Product Support Shimadzu UK Ltd) | Support Manager / Service Manager | Shimadzu (Group) | United Kingdom (GB) |
| Todd, Rebecca (Longwall Ventures 202212) | n. a. | Longwall Ventures (Group) | United Kingdom (GB) |
| Tolley, Arron (Aptamer Group 2008– CEO + Co-Founder) | Chief Executive Officer (CEO) | Aptamer Group (Group) | United Kingdom (GB) |
| Tomasello, Shawn (Oxford BioTherapeutics 201510– Board Director before Pharmacyclics + Celgene + Genentech) | Board member, non-executive | Oxford BioTherapeutics Ltd. (OBT) | United Kingdom (GB) |
| Tomlinson, Ian (MRC + Domantis) | n. a. | United Kingdom (GB) (govt) | United Kingdom (GB) |
| Toogood, Ben (Sino Biopharm 202206 CEO of invoX) | Chief Executive Officer (CEO) | Sino Biopharm (Group) | United Kingdom (GB) |
| Torbett, Neil (PhoreMost 202203– CEO joined 201701 as CBO befire Activiomics + Piramed Pharma) | Chief Executive Officer (CEO) | PhoreMost Ltd. | United Kingdom (GB) |
| Torbett, Richard (ABPI 202011 Chief Executive) | Chief Executive Officer (CEO) | ABPI (Association of the British Pharmaceutical Industry) | United Kingdom (GB) |
| Torrance, Chris (PhoreMost 201504– CEO + Co-founder before Horizon Discovery Co-founder + Vernalis) | Chief Executive Officer (CEO) | PhoreMost Ltd. | United Kingdom (GB) |
| Totten, Wilson (ProStrakan 200609 CEO) | Chief Executive Officer (CEO) | Kyowa Kirin (Group) | United Kingdom (GB) |
| Tottey, Philip (Redx Pharma 201601–201609 CFO LEFT 9/16) | Chief Financial Officer (CFO) | Redx Pharma (Group) | United Kingdom (GB) |
| Toumazou, Christofer (Chris) (DNA Electronics 201011 CEO) | Chief Executive Officer (CEO) | DNA Electronics (DNAe) (Group) | United Kingdom (GB) |
| Toyne-Sewell, Melanie (Instinctif Partners 201509) | Public Relations Manager / Investor Relations Manager | Instinctif Partners (Group) | United Kingdom (GB) |
| Trace, Mike (FTI Consulting 202108) | Public Relations Manager / Investor Relations Manager | FTI Consulting (Group) | United Kingdom (GB) |
| Tracey, Glenn (Microsaic 201709– CEO joined 201503 as COO before Cambridge Temperature Concepts + PerkinElmer) | Chief Executive Officer (CEO) | Microsaic Systems plc (AIM: MSYS) | United Kingdom (GB) |
| Tracz, Vitek (Current Science Group 200503) | n. a. | Science Navigation Group | United Kingdom (GB) |
| Travers, Stuart (Sentinel Oncology 201605 COO) | Chief Operating Officer (COO) | Sentinel Oncology Ltd. | United Kingdom (GB) |
| Traversone, Andrea (Amadeus Capital 202009 Managing Partner) | Managing Partner (investment firm) | Amadeus Capital (Group) | United Kingdom (GB) |
| Treanor, Rob (Sphere Fluidics 201903– Director of Operations) | Chief Operating Officer (COO) | Sphere Fluidics (Group) | United Kingdom (GB) |
| Treherne, Mark (Cellesce 201912 CEO) | Board member, non-executive | Danaher (Group) | United Kingdom (GB) |
| Tricarico, Martin (Whatman 200608 VP) | n. a. | General Electric (Group) | United Kingdom (GB) |
| Trickett, Lindsey (F-star 202110 VP Investor Relations + Communications before Intellia Therapeutics) | public relations / investor relations | Sino Biopharm (Group) | United Kingdom (GB) |
| Trim, Steven (Venomtech Ltd 201704 Managing Director + Founder) | Managing Director | Venomtech Ltd. | United Kingdom (GB) |
| Tripathi, Vineeta (Vitarka Therapeutics 2021– CEO + Founder before Boehringer Ingelheim + Ipsen Bioinnovation) | Chief Executive Officer (CEO) | Vitarka Therapeutics Ltd. | United Kingdom (GB) |
| Trowbridge, Lynne (Abcam 201911 VP External Communications formerly Instinctif + College Hill Life Sciences) | Public Relations Manager / Investor Relations Manager | Abcam (Group) | United Kingdom (GB) |
| Trower, Mike (Nerre Therapeutics 201403 COO) | Chief Operating Officer (COO) | Nerre Therapeutics Ltd. | United Kingdom (GB) |
| Truesdale, Mark (Solentim 202003– CEO joined 201910– as Chief Marketing Officer before Thermo Fisher + Genetix) | Chief Executive Officer (CEO) | Solentim (Group) | United Kingdom (GB) |
| Trundle, Frank (Shimadzu 200103 Business Manager at Kratos Analytical) | Business Development Manager / Strategy Manager | Shimadzu (Group) | United Kingdom (GB) |
| Tschollar, Werner (Xytis 200501 founder) | Company Founder | Xytis (Group) | United Kingdom (GB) |
| Tselentis, Paul (24Haymarket 202011 CEO) | Investment Manager | 24Haymarket Ltd. | United Kingdom (GB) |
| Tsita, Katerina (Roslin Cell Therapies 202006 Marketing Executive) | Sales Manager / Marketing Manager | RoslinCT (Group) | United Kingdom (GB) |
| Tsoneva, Daniela (Mercia 202211 Investment Manager VCT Funds + Turbine 202211– Board Director) | Investment Manager | Mercia (Group) | United Kingdom (GB) |
| Tucker, Mark (g-Nostics 2004 CEO) | Chief Executive Officer (CEO) | g-Nostics Ltd. | United Kingdom (GB) |
| Tudor, Dave (United Kingdom (govt) 202308 Managing Director of Pharmaceuticals at CPI) | Managing Director | United Kingdom (GB) (govt) | United Kingdom (GB) |
| Tunaboylu, Murat (Antiverse 202103 CEO + Co-Founder) | Chief Executive Officer (CEO) | Antiverse Ltd. | United Kingdom (GB) |
| Tuncer, Özgür (Stablepharma 202212 CEO) | Chief Executive Officer (CEO) | Stablepharma (Group) | United Kingdom (GB) |
| Turner, Simon (Alacrita 201706) | Consultant (economic/technology) | Alacrita (Group) | United Kingdom (GB) |
| Tween, Neil (Owlstone 202003– CFO at Owlstone Medical before GW Pharmaceuticals + Jagex + Deloitte) | Chief Financial Officer (CFO) | Owlstone (Group) | United Kingdom (GB) |
| Tyler, Christopher (Porvair 200409– Finance Director before Cable & Wireless) | Chief Financial Officer (CFO) | Porvair (Group) | United Kingdom (GB) |
| Tzouliadis, Katie (KTZ Communications 201602 Chief Executive + Founder before Biddick Associates) | Public Relations Manager / Investor Relations Manager | KTZ Communications Ltd. | United Kingdom (GB) |
| Tzouvalis, Plato (Acrongenomics 200704 President) | n. a. | Acrongenomics Inc. | United Kingdom (GB) |
| Underwood, David (Quanticate 201111 CEO) | Chief Executive Officer (CEO) | Quanticate (Group) | United Kingdom (GB) |
| Underwood, George (Huntsworth 202109 at Medistrava Consulting) | Public Relations Manager / Investor Relations Manager | Inizio (Group) | United Kingdom (GB) |
| Upton, Ross (Ultromics 202108 CEO + Co-Founder) | Chief Executive Officer (CEO) | Ultromics Ltd. | United Kingdom (GB) |
| Ureta-Vidal, Abel (Eagle Genomics 201805– Chief Product Officer before CEO + COO + Founder) | Product Manager (personnel) | Eagle Genomics Ltd. | United Kingdom (GB) |
| Vachon, Mark (GE Healthcare 200807 President + CEO Global Diagnostic Imaging Business) | President/Director/Head Business Group/Unit/Division | General Electric (Group) | United Kingdom (GB) |
| Vahlgren, Ole (Otsuka 201307 CEO of Otsuka Pharmaceutical Europe Ltd) | Chief Executive Officer (CEO) | Otsuka (Group) | United Kingdom (GB) |
| Vallance, Patrick (GSK 201302 President Pharmaceuticals RnD) | President/Director/Head Business Group/Unit/Division | GSK (Group) | United Kingdom (GB) |
| van Someren, Alex (Amadeus Capital 201401 Managing Partners of Early Stage funds) | Managing Partner (investment firm) | Amadeus Capital (Group) | United Kingdom (GB) |
| VanBogelen, Ruth (NextGen 200805– Director Biomarker Proteomics before Pfizer) | n. a. | NextGen (Group) | United Kingdom (GB) |
| Vanhaesebroeck, Bart (Univ London 201004 Professor Institute of Cancer + scientific co-founder Activiomics) | Professor | University of London | United Kingdom (GB) |
| Vann, Christopher (Autolus 201707– COO before Roche) | Chief Operating Officer (COO) | Autolus Therapeutics plc (Nasdaq: AUTL) | United Kingdom (GB) |
| Vannineuse, Pierre (Alpha Blue Ocean 2017– CEO + Co-Founder) | Chief Executive Officer (CEO) | Alpha Blue Ocean (ABO) (GB) | United Kingdom (GB) |
| Varley, John (AstraZeneca 200607) | n. a. | AstraZeneca (Group) | United Kingdom (GB) |
| Vasarotti, Enzo (Vivascience 200008 founder + co-partner) | Company Founder | Sartorius (Group) | United Kingdom (GB) |
| Vaschetto, Mariana (Dotmatics 201307 VP Marketing) | n. a. | Insightful Science (Group) | United Kingdom (GB) |
| Vellacott, Richard (Horizon Discovery 201207– CFO before VP Finance at CSR plc before Deloitte) | Chief Financial Officer (CFO) | PerkinElmer (Group) | United Kingdom (GB) |
| Venables, David (Laverock Therapeutics 202309 CEO formerly Synpromics 201508 CEO) | Chief Executive Officer (CEO) | Laverock Therapeutics Ltd. | United Kingdom (GB) |
| Veraitch, Farlan (Ori Biotech 202005 CSO + Co-Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Ori Biotech (Oribiotech) (Group) | United Kingdom (GB) |
| Verheyen, Jeroen (Semarion 201808– CEO + Co-Founder) | Chief Executive Officer (CEO) | Semarion Ltd. | United Kingdom (GB) |
| Vernon, N. Geoffrey | n. a. | Ziggus Holding Ltd. | United Kingdom (GB) |
| Vesey, John (United Kingdom (govt) 201905 Business Manager Health at Satellite Applications Catapult) | Business Development Manager / Strategy Manager | United Kingdom (GB) (govt) | United Kingdom (GB) |
| Viant, Mark (Univ Birmingham 201303 Professor) | Professor | University of Birmingham | United Kingdom (GB) |
| Vicary, James (NuNano 201711 Managing Director + Co-Founder) | Managing Director | NuNano (GB) | United Kingdom (GB) |
| Viehbacher, Christopher A. (Chris) (Biogen 202307 CEO before Gurnet Point Capital + Sanofi + GSK) | Managing Partner | BERTARELLI Group (family of Ernesto Bertarelli) | United Kingdom (GB) |
| Vile, Hollie (Optimum Strategic Communicatons 201710 before Hume Brophy + M:Communications) | Public Relations Manager / Investor Relations Manager | Optimum Strategic Communications | United Kingdom (GB) |
| VInce, Valérie (KWS Biotest 201511– Business Development Manager joined 2008 before Imperial College London) | Business Development Manager / Strategy Manager | Charles River (Group) | United Kingdom (GB) |
| Virji, Sukaina (Suki) (Consilium 201706– joins London CSC office before 16y at Scrip/Informa) | Public Relations Manager / Investor Relations Manager | ICR (Group) | United Kingdom (GB) |
| Vogel, Daniel (Genomics plc 202010– CFO before Carwow + Compare Global Group + Goldman Sachs) | Chief Financial Officer (CFO) | Genomics plc | United Kingdom (GB) |
| von Benecke, John (Locate Bio 20404 CEO) | Chief Executive Officer (CEO) | Locate Bio Ltd. | United Kingdom (GB) |
| von Jako, Ron (GE Healthcare 200807 CMO + Surgical Developm Leader) | Chief Medical Officer (CMO) | General Electric (Group) | United Kingdom (GB) |
| von Will, Tristana (Biochrom Ltd 201306 Product Marketing Manager) | Sales Manager / Marketing Manager | Harvard Bioscience (Group) | United Kingdom (GB) |
| Vosloo, Mark (Techcomp 201310– CEO of Edinburgh Instruments before Linos Photonics Ltd + Horiba Jobin Yvon Ltd) | Chief Executive Officer (CEO) | Techcomp (Group) | United Kingdom (GB) |
| Vosloo, Nicola (PerkinElmer 201102 PerkinElmer (UK) Ltd) | n. a. | PerkinElmer (Group) | United Kingdom (GB) |
| Wade-Gery, Laura (Marks & Spencer + Tesco) | Board member, non-executive | Adaptimmune (Group) | United Kingdom (GB) |
| Wagner, David (GSK 201005 Section Manager DMPK Group) | n. a. | GSK (Group) | United Kingdom (GB) |
| Wake, Ashleigh (Intertek 201509 Biopharmaceutical Services Leder) | President/Director/Head Business Group/Unit/Division | Intertek (Group) | United Kingdom (GB) |
| Walder, Adrienne (Alto Marketing 201010 Account Director) | Public Relations Manager / Investor Relations Manager | Alto Marketing Ltd. | United Kingdom (GB) |
| Walker, Anthony (Alacrita 2009– Founding Partner before Onyvax CEO + co-founder before consultant) | Company Founder | Alacrita (Group) | United Kingdom (GB) |
| Walker, Cheri (Abcam 201911 SVP Corp Development formerly Charles River+ Qiagen + Invitrogen + Deutsche Bank) | Business Development Manager / Strategy Manager | Abcam (Group) | United Kingdom (GB) |
| Walker, Jerry (Lab21 –200710– CEO) | Chief Executive Officer (CEO) | Novacyt (Group) | United Kingdom (GB) |
| Walker, Paul (Spectris 201309 Managing Director of Malvern Instruments Ltd) | Managing Director | Spectris (Group) | United Kingdom (GB) |
| Walker, Ross (Oxford RF Sensors 200506 CEO) | Chief Executive Officer (CEO) | Oxford NanoLabs Ltd. | United Kingdom (GB) |
| Walker, Sarah (OBN 201905 Senior Events Manager) | Event Manager / Conference Manager | OBN (UK) Ltd. | United Kingdom (GB) |
| Wall, Jane (BIA 202401– Managing Director before Business Development + Membership Services) | Managing Director | BioIndustry Association (BIA) (GB) | United Kingdom (GB) |
| Wallace, Paul (Mission Therapeutics 201503– CBO before Medivir AB Head of Business Development) | Chief Business Officer (CBO) | Mission Therapeutics Ltd. | United Kingdom (GB) |
| Wallace, Paul (QCMD 201310 Managing Director) | Managing Director | Quality Control for Molecular Diagnostics Ltd. (QCMD) | United Kingdom (GB) |
| Wallace, Wallace (Univ Oxford 202203– Associate LS at Oxford Science Enterprises before M Ventures + Accenture) | venture capital | Oxford Science Enterprises (Group) | United Kingdom (GB) |
| Waller, John (OracleBio 201111 Director) | President/Director/Head Business Group/Unit/Division | OracleBio Ltd. | United Kingdom (GB) |
| Wallis, Tim (Ridgeway Biologicals 201701 Managing Director) | Managing Director | Klocke (Group) | United Kingdom (GB) |
| Walls, Matthew (EpiStem 200704 CEO) | Chief Executive Officer (CEO) | Genedrive (Group) | United Kingdom (GB) |
| Walmsley, Emma (GSK 201704– CEO before CEO of GSK Consumer Healthcare division joined GSK 2010 from L’Oréal) | Chief Executive Officer (CEO) | GSK (Group) | United Kingdom (GB) |
| Walport, Mark (Wellcome Trust 2010 Director) | n. a. | Wellcome Trust, The | United Kingdom (GB) |
| Walsh, Andrew (Cambridge Enterprise 200804 Technology Manager) | IP Manager | University of Cambridge | United Kingdom (GB) |
1 2 3 ... 39 40 41 42
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
